Join industry leaders — register in seconds.
President, Jodas Expoim Pvt. Ltd.
Dr. Tathagata Dutta is the President of Jodas Expoim and a pioneer of drug and gene delivery and gene therapy in India. Across more than two decades in global pharma he has held President, CSO, Executive Director, and Managing Director & CEO roles at multinational companies, spanning R&D, operations, and quality. He holds a PhD in Pharmaceutical Sciences from Dr. Hari Singh Gour University, Sagar, completed postdoctoral research on RNAi Therapeutics at the University of Queensland, Brisbane, Australia and is an alumnus of IIM Calcutta. He is also a graduate in Law with Specialization in Intellectual Property Rights and International Arbitration. His work spans liposomes, nanoparticles, dendrimers, microspheres, complex injectable, Vaccines, Biologics and RNAi therapeutics, with numerous patents, publications, and national and international awards. He has been featured on the cover page of multiple magazines and is associated with multiple international bodies and NGOs in different capacities.
Founded in 2006 and headquartered in Hyderabad, Jodas Expoim is a specialty, innovation-driven generic pharmaceutical company, with its manufacturing facility and Innovation Center at Genome Valley, Telangana. Its portfolio spans anti-infectives, oncology, contrast media, and critical care — largely injectables — with products approved across 50+ countries and clearances from nine regulatory bodies including the EU, PIC/S, and SFDA.
Connecting plant, quality, and digital strategy.
Moving novel delivery systems from lab to scale.
Improving yield, uptime, and batch consistency.
Data integrity, traceability, and audit readiness.
Connecting equipment, MES, and batch records.
Cutting waste, energy, and emissions.
Building visibility across the production network.
Meeting rising client and regulator expectations.
Planning for scale-up and compliance early.
Join industry leaders for this exclusive deep‑dive into the future of pharma manufacturing.
Our site uses cookies. By using this site, you agree to the Privacy Policy and Terms of Use.